| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.6 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as critical, has been found in Hccgmbh mycare2x. The affected element is an unknown function. This manipulation of the argument lang causes sql injection. This vulnerability appears as CVE-2012-4261. The attack may be initiated remotely. In addition, an exploit is available.
Details
A vulnerability has been found in Hccgmbh mycare2x (Health Information Software) (affected version unknown) and classified as critical. Affected by this vulnerability is an unknown functionality. The manipulation of the argument lang with an unknown input leads to a sql injection vulnerability. The CWE definition for the vulnerability is CWE-89. The product constructs all or part of an SQL command using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the intended SQL command when it is sent to a downstream component. As an impact it is known to affect confidentiality, integrity, and availability. The summary by CVE is:
SQL injection vulnerability in modules/patient/mycare2x_pat_info.php in myCare2x allows remote attackers to execute arbitrary SQL commands via the lang parameter.
The weakness was presented 08/13/2012 (Website). The advisory is shared at osvdb.org. This vulnerability is known as CVE-2012-4261 since 08/13/2012. The exploitation appears to be easy. The attack can be launched remotely. The exploitation doesn't need any form of authentication. Technical details and also a public exploit are known. MITRE ATT&CK project uses the attack technique T1505 for this issue.
It is possible to download the exploit at exploit-db.com. It is declared as proof-of-concept.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at X-Force (75390), Exploit-DB (18844), OSVDB (81684†) and Secunia (SA49029†). See VDB-61574 and VDB-61572 for similar entries. If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.3VulDB Meta Temp Score: 6.6
VulDB Base Score: 7.3
VulDB Temp Score: 6.6
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Sql injectionCWE: CWE-89 / CWE-74 / CWE-707
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Access: Public
Status: Proof-of-Concept
Download: 🔍
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Exploit-DB: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
08/13/2012 🔍08/13/2012 🔍
08/13/2012 🔍
03/23/2015 🔍
01/27/2025 🔍
Sources
Advisory: osvdb.org⛔Status: Not defined
CVE: CVE-2012-4261 (🔍)
GCVE (CVE): GCVE-0-2012-4261
GCVE (VulDB): GCVE-100-61573
X-Force: 75390
Secunia: 49029
OSVDB: 81684
scip Labs: https://www.scip.ch/en/?labs.20161013
See also: 🔍
Entry
Created: 03/23/2015 16:50Updated: 01/27/2025 04:26
Changes: 03/23/2015 16:50 (47), 03/15/2019 20:18 (3), 01/27/2025 04:26 (27)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.